Cullinan Therapeutics, Inc. (CGEM)
NASDAQ·Healthcare·Medical - Pharmaceuticals
$13.51
+4.08%
Mkt Cap $830.30M
Analyst Ratings
Buy
9
Hold
0
Sell
0
Price Target (16 analysts)
$31.29
Range $26.00 – $38.00
Implied Upside
+131.6%
Consensus $31.29 vs current $13.51